ARCHIVES

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

This article is from The Cancer Letter archive.

Vol. 36 No. 28 | July 23, 2010

Download PDF Visit The Full Archive

Related Articles

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

CGAP Speeding Gene Discovery

April 30, 1999

NCI Director Says Gallo’s Work On HIV Should Have Been Recognized.

October 10, 2008

Funding Opportunities

March 7, 2003